{name}
{subtitle}
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~47 mi. (Rolla, Missouri, +825 more cities)
facility
Delbert Day Cancer Institute at PCRMC
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
city
~47 mi. (Rolla, Missouri, +327 more cities)
facility
Delbert Day Cancer Institute at PCRMC, +1 more facility
drug
bortezomib, +3 more drugs
drug type
chemotherapy, +3 more types
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
city
~47 mi. (Rolla, Missouri, +160 more cities)
facility
Delbert Day Cancer Institute at PCRMC
drug
cisplatin, +4 more drugs
drug type
chemotherapy, +1 more type
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
city
~47 mi. (Rolla, Missouri, +469 more cities)
facility
Mercy Clinic-Rolla-Cancer and Hematology, +1 more facility
drug
carboplatin, +6 more drugs
drug type
chemotherapy, +2 more types